NEULAND LABORATORIES
Back to Cashflow Statement
|
NEULAND LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-56 Cr | ₹44 Cr | ₹42 Cr | ₹40 Cr | ₹2.59 Cr |
What is the latest Net Cash Inflow / Outflow ratio of NEULAND LABORATORIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-56 Cr |
| Mar2025 | ₹44 Cr |
| Mar2024 | ₹42 Cr |
| Mar2023 | ₹40 Cr |
| Mar2022 | ₹2.59 Cr |
How is Net Cash Inflow / Outflow of NEULAND LABORATORIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-56 Cr | Negative | |
| Mar2025 | ₹44 Cr | 4.74 | |
| Mar2024 | ₹42 Cr | 5.74 | |
| Mar2023 | ₹40 Cr | 1,438.86 | |
| Mar2022 | ₹2.59 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹25,211.9 Cr | 0.4% | -9.7% | 21.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 0.4% |
-9.7% |
21.3% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses